Johnson & Johnson (JNJ)
268.36
-6.87
(-2.50%)
USD |
NYSE |
Sep 08, 11:51
Johnson & Johnson Profit Margin (Quarterly) : 21.86% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.86% |
| March 31, 2026 | 21.75% |
| December 31, 2025 | 20.83% |
| September 30, 2025 | 21.47% |
| June 30, 2025 | 23.32% |
| March 31, 2025 | 50.24% |
| December 31, 2024 | 15.24% |
| September 30, 2024 | 11.99% |
| June 30, 2024 | 20.87% |
| March 31, 2024 | 15.22% |
| December 31, 2023 | 19.32% |
| September 30, 2023 | 20.19% |
| June 30, 2023 | 24.97% |
| March 31, 2023 | -2.35% |
| December 31, 2022 | 16.17% |
| September 30, 2022 | 21.53% |
| June 30, 2022 | 20.03% |
| March 31, 2022 | 21.96% |
| December 31, 2021 | 19.09% |
| September 30, 2021 | 15.71% |
| June 30, 2021 | 26.94% |
| March 31, 2021 | 27.78% |
| December 31, 2020 | 7.73% |
| September 30, 2020 | 16.86% |
| June 30, 2020 | 19.77% |
| Date | Value |
|---|---|
| March 31, 2020 | 28.02% |
| December 31, 2019 | 19.32% |
| September 30, 2019 | 8.45% |
| June 30, 2019 | 27.25% |
| March 31, 2019 | 18.71% |
| December 31, 2018 | 14.91% |
| September 30, 2018 | 19.34% |
| June 30, 2018 | 19.00% |
| March 31, 2018 | 21.86% |
| December 31, 2017 | -53.06% |
| September 30, 2017 | 19.16% |
| June 30, 2017 | 20.31% |
| March 31, 2017 | 24.84% |
| December 31, 2016 | 21.04% |
| September 30, 2016 | 23.96% |
| June 30, 2016 | 21.62% |
| March 31, 2016 | 25.47% |
| December 31, 2015 | 18.02% |
| September 30, 2015 | 19.61% |
| June 30, 2015 | 25.35% |
| March 31, 2015 | 24.81% |
| December 31, 2014 | 13.80% |
| September 30, 2014 | 25.71% |
| June 30, 2014 | 22.21% |
| March 31, 2014 | 26.08% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 30.88% |
| Merck & Co., Inc. | -8.06% |
| Pfizer Inc. | -1.64% |
| Bristol Myers Squibb Co. | 25.54% |
| Liquidia Corp. | 43.52% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 25.94% |
| Return on Assets | 10.65% |
| Return on Invested Capital | 16.05% |
| Gross Profit Margin (Quarterly) | 68.73% |
| Operating Margin (Quarterly) | 29.10% |
| Return on Net Operating Assets | 13.74% |